Study Completion. This Agreement will terminate when the Study is complete, which means the conclusion of all Protocol-required activities for all enrolled Study Subjects.
Study Completion. For purposes of this Agreement, the Study is considered complete after conclusion of all Protocol-required activities for all enrolled subjects; receipt by ABC of all Protocol-required data; and receipt of all payments due to either party.
Study Completion. 1. The Sponsor shall, within 90 days of the study completion, inform the State Institute for Drug Control and relevant Ethics Committees on completion of the study. Provided the completion of the study has been aborted, above mentioned period shall be reduced to 15 days.
2. The Contract may be terminated as
Study Completion. For purposes of this Agreement, the Study is considered complete after conclusion of all Protocol-required activities for all enrolled Study Subjects; receipt by Sponsor of all relevant Protocol- required data, Study documents; and receipt of all payments due to either party. a. Dokončení Studie. Pro účely této Smlouvy bude Studie pokládána za dokončenou po uzavření všech činností požadovaných podle Protokolu pro všechny zařazené Subjekty studie, poté, co Zadavatel obdrží všechny relevantní údaje vyžadované podle Protokolu a dokumenty ze Studie, a po přijetí všech plateb splatných kterékoli smluvní straně.
Study Completion. The end of the study is defined as the date of database lock. The Investigator will notify the IRB/IEC when the study has been completed.
Study Completion. The Sponsor shall, within 90 days of the study completion, inform the State Institute for Drug Control and relevant Ethics Committees on completion of the study. Provided the completion of the study has been aborted, above mentioned period shall be reduced to 15 days. The Contract may be terminated as follows: a) If at least one (1) Study subject has not been enrolled by the Key Enrollment Date then Sponsor may terminate this Contract in accordance with section 3 of this Article. Key Enrollment Date is defined as a 100th (hundredth) calendar day after Site Initiation Visit. b) The Sponsor or the Medical Facility is entitled to withdraw from the Contract that is effective on the day notice has been delivered to the last of parties in cases as follows: (i) Any of the Contract parties does not meet some provision of this Contract and does not eliminate the discrepancies within 60 days after obtaining a written request to do so; (ii) Any of the Contract parties performs settlement with its creditors or files a petition for bankruptcy; (iii) Any of the Contract parties ceases to be authorised to pursue its activities within the field in concern; (iv) The risk incurred by the subjects increases significantly; or (v) The necessary authorisation, approval, consent or exception are revoked or suspended, or expires without prolongation.
Study Completion. This Agreement will terminate b.
Study Completion. The study is considered completed with the last visit of the last subject undergoing the study. The final data from the investigational site will be sent to the sponsor (or designee) in a timely manner as agreed upon with the sponsor, following completion of the final subject visit at that site.
Study Completion. 1. The Sponsor shall, within 90 days of the study completion, inform the State Institute for Drug Control and relevant Ethics Committees on completion of the study. Provided the completion of the study has been aborted, above mentioned period shall be reduced to 15 days.
2. The Contract may be terminated as follows:
a) If at least one (1) Study subject has not been enrolled by the Key Enrollment Date then Sponsor may terminate this Contract in accordance with section 3 of this Article. Key Enrollment Date is defined as a 100th (hundredth) calendar day after Site Initiation Visit.
b) The Sponsor or the Provider is entitled to withdraw from the Contract that is effective on the day notice has been delivered to the last of parties in cases as follows:
(i) Any of the Contract parties does not meet some provision of this Contract and does not eliminate the discrepancies within 60 days after obtaining a written request to do so;
(ii) Any of the Contract parties performs settlement with its creditors or files a petition for bankruptcy;
(iii) Any of the Contract parties ceases to be authorised to pursue its activities within the field in concern;
(iv) The risk incurred by the
Study Completion. For purposes of this Agreement, "Study Completion" is defined as completion of all Protocol-required activities for all enrolled subjects and receipt, by Company, of a final Study Report.
